Stockholders' Deficiency (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Proceeds related to private placement offering, value		$ 3,501,975
Proceeds related to private placement offering, units		3,501,975
Proceeds related to private placement offering, per unit		$ 1.00
Amount received from officer		500,000
Amount classified as restricted cash		850,002
Aggregate intrinsic value of exercised	0
Weighted Average annual rate of option forfeiture	4.00%	4.00%
Weighted average fair value of the stock granted	$ 0.16	$ 0.91
Selling, general and administrative expenses	5,370,727	7,554,954
Stock-based compensation expense related to stock options/ warrants, unamortized	1,135,635
Stock-based compensation expense related to stock options/warrants, to be amortized	244,066
Weighted average remaining period	1 year 1 month 6 days
Common Stock to three holders of warrants		1,465,578
Common Stock to three holders of warrants, exercised		2,353,744
Common Stock to several holders of warrants		10,342,931
Common Stock to several holders of warrants, exercised		12,505,023
Stock-based compensation expense related for consultant warrants	(722)	(17,718)
Recorded salary expense	116,666	350,000
Stock-based compensation expense related to stock options/ warrants	698,015	558,286
Warrant [Member]
Aggregate intrinsic value of exercised		16,983,736
Weighted average fair value of the stock granted	$ 0.20	$ 1.34
Selling, general and administrative expenses	722
Stock-based compensation expense related to stock options/ warrants, unamortized	577,523
Stock-based compensation expense related to stock options/warrants, to be amortized	683
Weighted average remaining period	9 months 18 days
Grant date value performance based warrant, unamortized	576,840
Stock-based compensation expense related to stock options/ warrants	132,503	490,420
Series B Preferred Stock [Member]
Share issued upon conversion	11.39	8.22
Beneficial Conversion Feature Related to Incremental Shares	2,887,507
Beneficial Conversion Feature Related to Incremental Value	7,288,068	1,532,722
Accrued contractual dividends	298,918	279,380
Series A Preferred Stock [Member]
Series A Preferred Stock are available to be issued		44,443
Stock Option [Member]
Fair value of shares issued as compensation	10,646
Private Placement [Member]
Gross proceeds received	1,653,000	3,501,975
Net of expenses recorded	$ 115,245
Total Units sold	11,020,003	3,501,975
Total Units sold, per share	$ 0.15	$ 1.00